Literature DB >> 18485383

A novel nomogram to predict the probability of prostate cancer on repeat biopsy.

Luigi Benecchi1, Anna Maria Pieri, Massimo Melissari, Michele Potenzoni, Carmelo Destro Pastizzaro.   

Abstract

PURPOSE: We developed a predictive model that incorporates clinical data and prostate specific antigen kinetic from general practice to detect prostate cancer in patients with a previously negative prostate biopsy.
MATERIALS AND METHODS: From January 2001 to January 2007 data on 419 men who underwent repeat prostate biopsy with 12 or more cores were used to develop the nomogram. From February 2007 to June 2007 data on 63 men with the same criteria were used to validate the nomogram. The factors that we evaluated for the risk of a positive repeat prostate biopsy were patient age, digital rectal examination findings, total prostate specific antigen, the free-to-total prostate specific antigen ratio, prostate specific antigen density and slope, and previous high grade prostatic intraepithelial neoplasia.
RESULTS: On multivariate logistic regression all factors except age and prostate specific antigen showed significant ability to predict the outcome of 12-core repeat prostate biopsy. In the validation group the AUC of the predicted results from the model was 0.856 (95% CI 0.744-0.931), better than that of prostate specific antigen, the free-to-total prostate specific antigen ratio, and prostate specific antigen density and slope (p <0.05).
CONCLUSIONS: We successfully developed an accurate model to predict the outcome of repeat prostate biopsy. Adding the free-to-total prostate specific antigen ratio, digital rectal examination, prostate specific antigen and slope, and history of high grade prostatic intraepithelial neoplasia sharply improves the accuracy of our model.

Entities:  

Mesh:

Year:  2008        PMID: 18485383     DOI: 10.1016/j.juro.2008.03.043

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.

Authors:  Andrew J Vickers; Tineke Wolters; Caroline J Savage; Angel M Cronin; M Frank O'Brien; Monique J Roobol; Gunnar Aus; Peter T Scardino; Jonas Hugosson; Fritz H Schröder; Hans Lilja
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

Review 2.  Addressing the need for repeat prostate biopsy: new technology and approaches.

Authors:  Michael L Blute; E Jason Abel; Tracy M Downs; Frederick Kelcz; David F Jarrard
Journal:  Nat Rev Urol       Date:  2015-07-14       Impact factor: 14.432

3.  Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.

Authors:  Shu-Chun Kuo; Shun-Hsing Hung; Hsien-Yi Wang; Chih-Chiang Chien; Chin-Li Lu; Hung-Jung Lin; How-Ran Guo; Jian-Fang Zou; Chian-Shiung Lin; Chien-Cheng Huang
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

4.  Prediction of prostate cancer by deep learning with multilayer artificial neural network.

Authors:  Takumi Takeuchi; Mami Hattori-Kato; Yumiko Okuno; Satoshi Iwai; Koji Mikami
Journal:  Can Urol Assoc J       Date:  2018-10-15       Impact factor: 1.862

5.  Predictors for the detection of prostate cancer and clinically significant prostate cancer using TRUS-guided biopsy in patients with negative initial biopsy results.

Authors:  Sangjun Yoo; Juhyun Park; Sung Yong Cho; Min Chul Cho; Ja Hyeon Ku; Hwancheol Son; Cheol Kwak; Hyeon Hoe Kim; Hyeon Jeong
Journal:  World J Urol       Date:  2018-03-01       Impact factor: 4.226

Review 6.  Optimization of prostate biopsy: review of technique and complications.

Authors:  Marc A Bjurlin; James S Wysock; Samir S Taneja
Journal:  Urol Clin North Am       Date:  2014-05       Impact factor: 2.241

7.  Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.

Authors:  J Schiffmann; P Tennstedt; J Fischer; Zhe Tian; B Beyer; K Boehm; M Sun; G Gandaglia; U Michl; M Graefen; G Salomon
Journal:  World J Urol       Date:  2014-05-29       Impact factor: 4.226

8.  Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy.

Authors:  Jeannette Kratzenberg; Georg Salomon; Pierre Tennstedt; Paolo Dell'Oglio; Derya Tilki; Axel Haferkamp; Markus Graefen; Katharina Boehm
Journal:  World J Urol       Date:  2018-01-13       Impact factor: 4.226

9.  A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

Authors:  A Gupta; M J Roobol; C J Savage; M Peltola; K Pettersson; P T Scardino; A J Vickers; F H Schröder; H Lilja
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

10.  Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

Authors:  Raj Satkunasivam; William Zhang; John Trachtenberg; Ants Toi; Changhong Yu; Eleftherios Diamandis; Michael W Kattan; Steven A Narod; Robert K Nam
Journal:  Springerplus       Date:  2014-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.